Proxy Votes Now

Home › Funds › Brighthouse › T. Rowe Price Small Cap Growth Portfolio

T. Rowe Price Small Cap Growth Portfolio proxy voting record 2025-2026

Fund family: Brighthouse · Filed by Brighthouse Funds Trust II (CIK 710826) · SEC series S000006529

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,648 with, 9 against, 0 abstentions (not counted as with management); 8 items carried no recommendation. Shareholder proposals: 3 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Brighthouse as a whole

The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBrighthouseItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.8%2,58776.3%204,500
Backed environmental and social shareholder proposals at US companiesn/a312.8%1,182

Where this fund voted differently from most Brighthouse funds

Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Brighthouse funds on 244 items (12.2% of the 2,001 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkForWITHHOLD — 8 of 8 Brighthouse fundsForElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaForWITHHOLD — 8 of 8 Brighthouse fundsForElected, 75.5% support
SiTime Corporation2026-05-29To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.ForABSTAIN or AGAINST — 8 of 8 Brighthouse fundsForApproved, 82.1% support
DigitalOcean Holdings, Inc.2026-06-15Election of Class II Directors: Pueo KefferForWITHHOLD — 8 of 8 Brighthouse fundsForPassed (calculated), 83.8% support
DigitalOcean Holdings, Inc.2026-06-15Election of Class II Directors: Warren AdelmanForWITHHOLD — 8 of 8 Brighthouse fundsForPassed (calculated), 79.8% support
Repligen Corporation2026-05-14Election of Directors: Carrie Eglinton MannerForAGAINST or ABSTAIN — 7 of 7 Brighthouse fundsForElected, 81.0% support
Repligen Corporation2026-05-14Election of Directors: Glenn P. MuirForAGAINST or ABSTAIN — 7 of 7 Brighthouse fundsForElected, 74.4% support
Repligen Corporation2026-05-14Election of Directors: Karen A. DawesForAGAINST or ABSTAIN — 7 of 7 Brighthouse fundsForElected, 82.4% support
FirstCash Holdings, Inc.2026-06-09Approve the reincorporation of the Company to the State of Texas by conversion.ForABSTAIN or AGAINST — 7 of 7 Brighthouse fundsForApproved, 58.4% support
Laureate Education, Inc.2026-05-21To approve the Laureate Education, Inc. 2026 Long-Term Incentive Plan.AgainstFOR — 7 of 7 Brighthouse fundsAgainstPassed (calculated), 94.6% support
Entegris, Inc.2026-05-06To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders.ForABSTAIN or AGAINST — 6 of 6 Brighthouse fundsForPassed (calculated), 83.6% support
BrightSpring Health Services, Inc.2026-05-21Election of Class II directors: Steve MillerForWITHHOLD — 6 of 6 Brighthouse fundsForPassed (calculated), 76.7% support
The Ensign Group, Inc.2026-05-13ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Barry M. SmithAgainstFOR — 6 of 6 Brighthouse fundsAgainstElected, 92.3% support
The Ensign Group, Inc.2026-05-13ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Ms. Swati B. AbbottAgainstFOR — 6 of 6 Brighthouse fundsAgainstElected, 93.1% support
Procore Technologies, Inc.2026-06-04To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officersForAGAINST or ABSTAIN — 5 of 5 Brighthouse fundsForApproved, 63.1% support
Teradata Corporation2026-05-14Election of Directors: Kimberly K. NelsonAgainstFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 90.4% support
Ocular Therapeutix, Inc.2026-06-10To approve an advisory vote on named executive officer compensation.ForABSTAIN or AGAINST — 5 of 5 Brighthouse fundsFor—
Rambus Inc.2026-04-23Election of Directors: Meera RaoAgainstFOR — 9 of 11 Brighthouse fundsAgainstPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerAgainstFOR — 9 of 11 Brighthouse fundsAgainstPassed (calculated), 93.5% support
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Barbara BurgerForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 84.2% support
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Eddy ZervigonForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 76.8% support
Insmed Incorporated2026-05-13Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.WithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 88.5% support
Insmed Incorporated2026-05-13Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee AndersonWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 82.7% support
Nextracker Inc.2025-08-18The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey GuldnerForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 74.3% support
Coca-Cola Consolidated, Inc.2026-05-12Election of the 11 nominees as directors: James R. Helvey, IIIWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.8% support
Show all 244
Items 26 to 244.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Watts Water Technologies, Inc.2026-05-19Election of Directors: Suzanne L. StefanyWithholdFOR — 4 of 4 Brighthouse fundsAgainstElected, 98.5% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellWithholdFOR — 4 of 4 Brighthouse fundsAgainstElected, 83.0% support
Fabrinet2025-12-11Election of Directors: Dr. Homa BahramiWithholdFOR — 4 of 4 Brighthouse fundsAgainstElected, 91.1% support
The Toro Company2026-03-17Election of Directors: D. Christian KochWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 87.0% support
The Toro Company2026-03-17Election of Directors: Dianne C. CraigWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 96.5% support
The Toro Company2026-03-17Election of Directors: Eric P. HansotiaWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 94.6% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungForWITHHOLD — 4 of 4 Brighthouse fundsForPassed (calculated), 85.5% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy WalbertForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 69.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 4 of 4 Brighthouse fundsForElected, 95.6% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 86.8% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina BurowForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 81.6% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael GilmanForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 78.2% support
Cavco Industries, Inc.2025-07-29Election of Directors: David A. GreenblattAgainstFOR — 4 of 4 Brighthouse fundsAgainstElected, 89.9% support
Cavco Industries, Inc.2025-07-29Election of Directors: Julia W. SzeAgainstFOR — 4 of 4 Brighthouse fundsAgainstElected, 97.1% support
Cavco Industries, Inc.2025-07-29Election of Directors: Richard A. KerleyAgainstFOR — 4 of 4 Brighthouse fundsAgainstElected, 95.6% support
The Brink's Company2026-06-30Proposal to adjourn the Brink's Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there is not a quorum or there are not sufficient votes to approve the Brink's Share Issuance Proposal or to ensure that any supplement or amendment AgainstFOR — 4 of 4 Brighthouse fundsAgainst—
Beam Therapeutics Inc.2026-06-03Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi ShawForABSTAIN or AGAINST — 4 of 4 Brighthouse fundsForElected, 90.5% support
Beam Therapeutics Inc.2026-06-03Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D.ForABSTAIN or AGAINST — 4 of 4 Brighthouse fundsForElected, 89.4% support
Stoke Therapeutics, Inc.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.ForAGAINST or ABSTAIN — 4 of 4 Brighthouse fundsForPassed (calculated), 72.9% support
Mineralys Therapeutics, Inc.2026-05-21Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D.ForWITHHOLD — 4 of 4 Brighthouse fundsForPassed (calculated), 60.6% support
Upwork Inc.2026-06-04Advisory vote to approve named executive officer compensation.ForAGAINST or ABSTAIN — 4 of 4 Brighthouse fundsForApproved, 72.0% support
Verra Mobility Corporation2026-05-19Elect three Class II directors, Patrick J. Byrne, David M. Roberts, and John H. Rexford, to serve on our Board until our 2029 Annual Meeting of Stockholders: John H. RexfordForWITHHOLD — 4 of 4 Brighthouse fundsForElected, 66.7% support
Moog Inc.2026-02-10Election of directors: Class A Director - Term Expiring 2029: Brenda ReichelderferWithholdFOR — 4 of 4 Brighthouse fundsAgainstElected, 95.0% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarWithholdFOR — 7 of 9 Brighthouse fundsAgainstElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniWithholdFOR — 7 of 9 Brighthouse fundsAgainstElected, 96.6% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. David J. WilsonAgainstFOR — 7 of 9 Brighthouse fundsAgainstPassed (calculated), 91.6% support
Modine Manufacturing Company2025-08-21Election of Directors: Ms. Katherine C. HarperAgainstFOR — 7 of 9 Brighthouse fundsAgainstPassed (calculated), 95.5% support
APi Group Corporation2026-05-15To elect nine directors for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Cyrus D. WalkerForAGAINST — 5 of 6 Brighthouse fundsForPassed (calculated), 81.1% support
Carpenter Technology Corporation2025-10-07Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Dr. Viola L. AcoffWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 96.1% support
Carpenter Technology Corporation2025-10-07Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Howard H. YuWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.2% support
Carpenter Technology Corporation2025-10-07Elect three directors of the corporation to serve for a term of three years and until their successors shall have been elected and qualified: Nomination for three-year term, expiring in 2028: Stephen M. Ward, Jr.WithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 86.1% support
BrightSpring Health Services, Inc.2026-05-21Election of Class II directors: Olivia KirtleyForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 85.4% support
Dynatrace, Inc.2025-08-20Election of Class II Directors: Amol KulkarniForAGAINST — 3 of 3 Brighthouse fundsForElected, 63.0% support
JFrog Ltd.2026-05-20Election of Directors: Elisa SteeleForAGAINST — 3 of 3 Brighthouse fundsForPassed (calculated), 70.7% support
Protagonist Therapeutics, Inc.2026-06-17To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D.ForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 86.1% support
Cognex Corporation2026-04-29Nominees: Nominated for a term ending in 2029: Angelos PapadimitriouAgainstFOR — 3 of 3 Brighthouse fundsAgainstElected, 87.0% support
Crocs, Inc.2026-06-09Election of Directors: Beth J. KaplanWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 96.7% support
Crocs, Inc.2026-06-09Election of Directors: Neeraj S. TolmareWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.4% support
Crocs, Inc.2026-06-09Election of Directors: Thomas J. SmachWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 89.5% support
Lyft, Inc.2026-06-03To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officersForABSTAIN — 3 of 3 Brighthouse fundsFor—
Churchill Downs Incorporated2026-04-21Election of Class III Directors: Daniel P. HarringtonWithholdFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 94.6% support
Churchill Downs Incorporated2026-04-21Election of Class III Directors: Douglas C. GrissomWithholdFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 90.0% support
e.l.f. Beauty, Inc.2025-08-21Election of Directors: Lori KeithForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 73.8% support
Ionis Pharmaceuticals, Inc.2026-06-04Election of Directors: Joan E. HermanAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 96.4% support
Birkenstock Holding Plc2026-04-29Amend Articles of AssociationForAGAINST — 3 of 3 Brighthouse fundsFor—
Birkenstock Holding Plc2026-04-29Elect Director Ruth KennedyForAGAINST — 3 of 3 Brighthouse fundsFor—
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 78.7% support
Balchem Corporation2026-06-18Election of Directors: Daniel KnutsonAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.4% support
Balchem Corporation2026-06-18Election of Directors: David FischerAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 93.1% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid RizviAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa AhlmanAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary BaglivoAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard ZanninoAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 95.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert FischAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.3% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley FleishmanAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 90.7% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen WhiteAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.5% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas HendricksonAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.0% support
Laureate Education, Inc.2026-05-21To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Andrew B. CohenForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 79.3% support
Laureate Education, Inc.2026-05-21To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Ian K. SnowForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 75.2% support
Planet Fitness, Inc.2026-05-05Election of the four director nominees named in the proxy statement as set forth below: Enshalla AndersonWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 92.2% support
Itron, Inc.2026-05-07Election of Directors: Frank M. JaehnertAgainstFOR — 5 of 6 Brighthouse fundsAgainstElected, 83.7% support
Itron, Inc.2026-05-07Election of Directors: Jerome J. LandeAgainstFOR — 5 of 6 Brighthouse fundsAgainstElected, 96.0% support
Itron, Inc.2026-05-07Election of Directors: Sanjay MirchandaniAgainstFOR — 5 of 6 Brighthouse fundsAgainstElected, 96.5% support
Bill Holdings, Inc.2025-12-11To elect the directors listed below: Allie KlineForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 80.5% support
Bill Holdings, Inc.2025-12-11To elect the directors listed below: David HornikForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 86.7% support
Lazard, Inc.2026-05-21Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan.ForAGAINST — 3 of 3 Brighthouse fundsForPassed (calculated), 60.9% support
Liquidia Corporation2026-06-16Election of Directors: Katie Rielly-GauvinForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 92.2% support
Liquidia Corporation2026-06-16Election of Directors: Ramandeep SinghForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 91.6% support
Cabot Corporation2026-03-12Election of Directors: Thierry VanlanckerAgainstFOR — 3 of 3 Brighthouse fundsAgainstElected, 94.6% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D.WithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 89.4% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan, M.D.WithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 85.4% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: John M. AlbertineAgainstFOR — 3 of 3 Brighthouse fundsAgainst—
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardAgainstFOR — 3 of 3 Brighthouse fundsAgainst—
Disc Medicine, Inc.2026-06-18To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.ForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 84.2% support
SiriusPoint Ltd.2026-05-20Election of two Class 1 director nominees for 3-year terms expiring in 2029: Susan L. CrossWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.3% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. FingerWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 89.0% support
ADMA Biologics, Inc.2026-06-02To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene SalasWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.6% support
Skyward Specialty Insurance Group, Inc.2026-05-05To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 annual meeting of stockholders: Gena AsheForWITHHOLD — 3 of 3 Brighthouse fundsForElected, 71.9% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Debra ZumwaltWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 88.2% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: H. Eugene LockhartWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 96.3% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Hugh E. SawyerWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 95.4% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: James H. RothWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.1% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: John McCartneyWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 94.0% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Joy T. BrownWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.0% support
Huron Consulting Group Inc.2026-05-08To elect to the board of directors the eight persons nominated by the board of directors to serve as directors: Peter K. MarkellWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 95.8% support
Axcelis Technologies, Inc.2026-02-06To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Axcelis Share Issuance Proposal.AgainstFOR — 3 of 3 Brighthouse fundsAgainst—
Stoke Therapeutics, Inc.2026-06-03Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D.ForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 73.0% support
Upwork Inc.2026-06-04Election of Class II directors to serve until the 2029 annual meeting of stockholders: Gary SteeleForAGAINST — 3 of 3 Brighthouse fundsForPassed (calculated), 82.1% support
Alumis Inc.2026-06-30To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D.ForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 84.1% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 75.7% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.ForWITHHOLD — 3 of 3 Brighthouse fundsForPassed (calculated), 74.5% support
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 6 of 8 Brighthouse fundsAgainstPassed (calculated), 97.0% support
Rhythm Pharmaceuticals, Inc.2026-06-24Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.ForABSTAIN or AGAINST — 6 of 8 Brighthouse fundsForApproved, 81.5% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Marchelle E. MooreAgainstFOR — 6 of 8 Brighthouse fundsAgainstElected, 90.9% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinAgainstFOR — 6 of 8 Brighthouse fundsAgainstElected, 93.9% support
Eagle Materials Inc.2025-08-04Election of Directors: George J. DamirisAgainstFOR — 6 of 8 Brighthouse fundsAgainstElected, 98.3% support
Eagle Materials Inc.2025-08-04Election of Directors: Martin M. EllenAgainstFOR — 6 of 8 Brighthouse fundsAgainstElected, 93.8% support
Weatherford International plc2026-06-11Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they consForAGAINST — 4 of 5 Brighthouse fundsForPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatelForAGAINST — 4 of 5 Brighthouse fundsForPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement.ForAGAINST — 4 of 5 Brighthouse fundsForPassed (calculated), 64.7% support
Weatherford International plc2026-06-11To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement.ForAGAINST — 4 of 5 Brighthouse fundsForPassed (calculated), 66.3% support
Waystar Holding Corp.2026-06-01Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John DriscollForWITHHOLD — 4 of 5 Brighthouse fundsForElected, 86.5% support
Ambarella, Inc.2026-06-26To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan.ForAGAINST or ABSTAIN — 4 of 5 Brighthouse fundsFor—
MP Materials Corp.2026-06-09Election of 2 Directors Named in the Proxy Statement: Arnold W. DonaldForWITHHOLD — 5 of 7 Brighthouse fundsForPassed (calculated), 85.2% support
MP Materials Corp.2026-06-09Election of 2 Directors Named in the Proxy Statement: Randall J. WeisenburgerForWITHHOLD — 5 of 7 Brighthouse fundsForPassed (calculated), 81.6% support
Permian Resources Corporation2026-05-19To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.ForAGAINST or ABSTAIN — 6 of 9 Brighthouse fundsForPassed (calculated), 71.8% support
MKS Inc.2026-05-11Shareholder A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting.AgainstFOR — 6 of 9 Brighthouse fundsForFailed (calculated), 32.6% support
ESCO Technologies Inc.2026-01-30Election of Directors: Robert J. PhillippyWithholdFOR — 6 of 9 Brighthouse fundsAgainstElected, 87.4% support
Natera, Inc.2026-06-11To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.ForABSTAIN or AGAINST — 9 of 16 Brighthouse fundsForPassed (calculated), 78.1% support
ATI Inc.2026-05-14Election of Directors: David J. MorehouseWithholdFOR — 5 of 8 Brighthouse fundsAgainstPassed (calculated), 92.1% support
RBC Bearings Incorporated2025-09-04To consider a resolution regarding the stockholder advisory vote on named executive officer compensation.ForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsForApproved, 81.1% support
BridgeBio Pharma, Inc.2026-06-22To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.ForABSTAIN or AGAINST — 5 of 8 Brighthouse fundsForApproved, 82.9% support
StandardAero, Inc.2026-06-253 wordings Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholder, and until their respective successors shall have been duly elected and qualified: Douglas V. BrandelyForWITHHOLD — 5 of 8 Brighthouse fundsForElected, 85.0% support
Cytokinetics, Incorporated2026-05-27Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D.WithholdFOR — 5 of 8 Brighthouse fundsAgainstPassed (calculated), 79.2% support
Kirby Corporation2026-04-27Election of three Class I Directors: Richard J. AlarioAgainstFOR — 5 of 8 Brighthouse fundsAgainstElected, 91.7% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Michael T. MillerForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsForElected, 96.1% support
CG Oncology, Inc.2026-06-04To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr.ForWITHHOLD — 5 of 8 Brighthouse fundsForElected, 92.3% support
Natera, Inc.2026-06-11To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notiWithholdFOR — 3 of 4 Brighthouse fundsAgainstPassed (calculated), 87.1% support
Natera, Inc.2026-06-11To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notiWithholdFOR — 3 of 4 Brighthouse fundsAgainstPassed (calculated), 84.7% support
Natera, Inc.2026-06-11To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notiWithholdFOR — 3 of 4 Brighthouse fundsAgainstPassed (calculated), 87.1% support
Entegris, Inc.2026-05-06Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders.AgainstFOR — 4 of 6 Brighthouse fundsForFailed (calculated), 31.3% support
Lamar Advertising Company2026-05-14Election of directors: Anna ReillyForWITHHOLD — 3 of 4 Brighthouse fundsForElected, 92.4% support
Lamar Advertising Company2026-05-14Election of directors: Kevin P. Reilly, Jr.ForWITHHOLD — 3 of 4 Brighthouse fundsForElected, 92.3% support
Lamar Advertising Company2026-05-14Election of directors: Wendell ReillyForWITHHOLD — 3 of 4 Brighthouse fundsForElected, 92.4% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil.ForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 93.0% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFAForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 93.6% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D.ForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 93.7% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D.ForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 94.9% support
Vaxcyte, Inc.2026-06-152 wordings Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.ForWITHHOLD — 3 of 4 Brighthouse fundsForPassed (calculated), 87.5% support
JFrog Ltd.2026-05-20As required by the Israeli Companies Law, to approve changes to the compensation of Shlomi Ben Haim, our Chief Executive Officer.ForAGAINST or ABSTAIN — 3 of 4 Brighthouse fundsFor—
JFrog Ltd.2026-05-20To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in the proxy statement.ForAGAINST or ABSTAIN — 3 of 4 Brighthouse fundsForPassed (calculated), 82.0% support
Weatherford International plc2026-06-11To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary shaForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsFor—
Dycom Industries Inc.2026-05-28Election of Directors: Peter T. Pruitt, Jr.AgainstFOR — 4 of 6 Brighthouse fundsAgainstPassed (calculated), 96.9% support
Concentra Group Holdings Parent, Inc.2026-04-30Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. WatkinsForAGAINST — 3 of 4 Brighthouse fundsForElected, 81.8% support
VSE Corporation2026-05-07Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.ForAGAINST or ABSTAIN — 3 of 4 Brighthouse fundsForApproved, 78.4% support
Cabot Corporation2026-03-12Election of Directors: Raffiq NathooAgainstFOR — 3 of 4 Brighthouse fundsAgainstElected, 96.9% support
Acadia Pharmaceuticals Inc.2026-05-29To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. DalyWithholdFOR — 3 of 4 Brighthouse fundsAgainstPassed (calculated), 97.7% support
OSI Systems, Inc.2025-12-11Election of Directors: Ajay MehraForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 97.4% support
OSI Systems, Inc.2025-12-11Election of Directors: Deepak ChopraForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 97.1% support
OSI Systems, Inc.2025-12-11Election of Directors: Gerald ChizeverForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 89.8% support
OSI Systems, Inc.2025-12-11Election of Directors: Kelli BernardForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsForElected, 93.6% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonWithholdFOR — 3 of 4 Brighthouse fundsAgainstElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingWithholdFOR — 3 of 4 Brighthouse fundsAgainstElected, 80.4% support
Vera Therapeutics, Inc.2026-05-21To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 95.9% support
Vera Therapeutics, Inc.2026-05-21To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 99.9% support
Ocular Therapeutix, Inc.2026-06-10To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation.ForABSTAIN — 3 of 4 Brighthouse fundsForPassed (calculated), 96.4% support
Nuvalent, Inc.2026-06-16Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.ForWITHHOLD — 3 of 4 Brighthouse fundsForElected, 81.5% support
Rambus Inc.2026-04-23Election of Directors: Charles KissnerAgainstFOR — 6 of 11 Brighthouse fundsAgainstPassed (calculated), 85.5% support
Kratos Defense & Security Solutions, Inc.2026-05-12To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation.ForABSTAIN or AGAINST — 6 of 11 Brighthouse fundsForApproved, 88.6% support
Nutanix, Inc.2025-12-12Approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForApproved, 92.1% support
Halozyme Therapeutics, Inc.2026-05-05Election of Class I Directors: Bernadette ConnaughtonAgainstFOR — 4 of 7 Brighthouse fundsAgainstPassed (calculated), 94.6% support
Halozyme Therapeutics, Inc.2026-05-05Election of Class I Directors: Matthew L. PosardAgainstFOR — 4 of 7 Brighthouse fundsAgainstPassed (calculated), 89.0% support
Halozyme Therapeutics, Inc.2026-05-05To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.ForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForApproved, 90.1% support
Carpenter Technology Corporation2025-10-07Approve the compensation of the corporation's named executive officers, in an advisory vote.ForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForApproved, 97.3% support
CACI International Inc.2025-10-16Election of Directors: Ryan D. McCarthyForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForElected, 89.9% support
FirstCash Holdings, Inc.2026-06-09Approve, by non-binding vote, the compensation of named executive officers as described in the Proxy Statement.ForABSTAIN — 4 of 7 Brighthouse fundsForApproved, 96.7% support
FirstCash Holdings, Inc.2026-06-09To ratify the selection of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.ForABSTAIN — 4 of 7 Brighthouse fundsForApproved, 97.5% support
Weatherford International plc2026-06-11To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement.ForAGAINST — 4 of 7 Brighthouse fundsForPassed (calculated), 63.9% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Aida M. AlvarezForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 97.8% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Allison LawrenceForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 98.1% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Joseph A. VerbruggeForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 97.9% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Liza McFaddenForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 93.6% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Ralph SmithForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 98.2% support
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: Steven B. FinkForWITHHOLD — 4 of 7 Brighthouse fundsForElected, 95.2% support
Medpace Holdings, Inc.2026-05-15Shareholder Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting.AgainstFOR — 3 of 5 Brighthouse fundsForFailed (calculated), 34.1% support
RBC Bearings Incorporated2025-09-04Election of Directors: Edward D. Stewart (Class I Director to serve a three-year term)AgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 77.0% support
Range Resources Corporation2026-05-13Election of Directors: Brenda A. ClineForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.1% support
Range Resources Corporation2026-05-13Election of Directors: Charles G. GriffieForABSTAIN — 3 of 5 Brighthouse fundsForElected, 98.9% support
Range Resources Corporation2026-05-13Election of Directors: Christian S. KendallForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.1% support
Range Resources Corporation2026-05-13Election of Directors: Dennis L. DegnerForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.7% support
Range Resources Corporation2026-05-13Election of Directors: Greg G. MaxwellForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.1% support
Range Resources Corporation2026-05-13Election of Directors: Margaret K. DormanForABSTAIN — 3 of 5 Brighthouse fundsForElected, 99.0% support
Range Resources Corporation2026-05-13Election of Directors: Reginal W. SpillerForABSTAIN — 3 of 5 Brighthouse fundsForElected, 96.7% support
Range Resources Corporation2026-05-13To consider and vote on a proposal to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm as of and for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 98.5% support
Globus Medical, Inc.2026-06-03Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert DouglasWithholdFOR — 3 of 5 Brighthouse fundsAgainstElected, 96.9% support
Madrigal Pharmaceuticals, Inc.2026-06-17Advisory vote to approve executive compensationForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 97.1% support
Madrigal Pharmaceuticals, Inc.2026-06-17Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase PlanForAGAINST — 3 of 5 Brighthouse fundsFor—
Madrigal Pharmaceuticals, Inc.2026-06-17Re-election of Class I directors: Daniel BrennanForWITHHOLD — 3 of 5 Brighthouse fundsForElected, 99.4% support
Madrigal Pharmaceuticals, Inc.2026-06-17To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 99.8% support
Krystal Biotech, Inc.2026-05-15Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 95.6% support
Krystal Biotech, Inc.2026-05-15To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 99.9% support
Protagonist Therapeutics, Inc.2026-06-17To approve the adoption of the Company's 2026 Equity Incentive Plan.ForAGAINST — 3 of 5 Brighthouse fundsForApproved, 84.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.AgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Rhythm Pharmaceuticals, Inc.2026-06-24Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirrForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 85.9% support
CAVA Group, Inc.2026-06-22Approval, on an advisory basis, of the compensation of our named executive officers.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 87.8% support
CAVA Group, Inc.2026-06-22Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 27, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 99.6% support
Louisiana-Pacific Corporation2026-05-01Election of Class II Directors: Jose A. BayardoAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 89.1% support
Louisiana-Pacific Corporation2026-05-01Election of Class II Directors: Stephen E. MacadamAgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 83.2% support
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 80.6% support
CorVel Corporation2025-08-07To approve the 2025 Stock Incentive Plan.AgainstFOR — 3 of 5 Brighthouse fundsAgainstPassed (calculated), 84.0% support
Ocular Therapeutix, Inc.2026-06-10To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares.ForABSTAIN — 3 of 5 Brighthouse fundsFor—
Ocular Therapeutix, Inc.2026-06-10To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 5 Brighthouse fundsForApproved, 98.9% support
Revolution Medicines, Inc.2026-06-18To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyForWITHHOLD — 2 of 3 Brighthouse fundsForPassed (calculated), 79.1% support
Medpace Holdings, Inc.2026-05-15To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
HubSpot, Inc.2026-06-15Approve the adjournment of the 2026 Annual Meeting of Stockholders (the "Annual Meeting") to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes for the approval of Proposals One through Four.AgainstFOR — 2 of 3 Brighthouse fundsAgainstApproved, 85.1% support
Ionis Pharmaceuticals, Inc.2026-06-04Election of Directors: Spencer R. BerthelsenAgainstFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 85.2% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term)AgainstFOR — 2 of 3 Brighthouse fundsAgainstElected, 97.6% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term)AgainstFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Powell Industries, Inc.2026-02-18To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Alaina K. BrooksWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 94.3% support
Powell Industries, Inc.2026-02-18To elect two (2) members of the Company's Board of Directors, with terms to expire in 2029: Katheryn B. CurtisWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 92.7% support
Core Scientific, Inc.2026-05-12Election of Directors: Yadin RozovWithholdFOR — 2 of 3 Brighthouse fundsAgainstElected, 96.8% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 2 of 3 Brighthouse fundsAgainstApproved, 68.0% support
Power Integrations, Inc.2026-06-03To approve the amendment and restatement of the Power Integrations, Inc. 2016 Incentive Award Plan to Increase the number of shares reserved for issuance thereunder.ForAGAINST — 2 of 3 Brighthouse fundsForApproved, 83.1% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dana WolfWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 97.5% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad TrivediWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 95.7% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Eric SingerWithholdFOR — 2 of 3 Brighthouse fundsAgainstPlurality election, 47.7% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. ChungWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 83.0% support
A10 Networks, Inc.2026-04-22To elect five directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. BrahamWithholdFOR — 2 of 3 Brighthouse fundsAgainstPassed (calculated), 97.6% support
Wave Life Sciences Ltd.2025-08-05The election of the nominees for director: Christian HenryForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 85.4% support
Wave Life Sciences Ltd.2025-08-05The election of the nominees for director: Ken TakanashiForAGAINST — 2 of 3 Brighthouse fundsForPassed (calculated), 95.4% support
Verra Mobility Corporation2026-05-19Approve, on an advisory basis (non-binding), the frequency of future advisory votes approving the compensation of our named executive officers.ForABSTAIN — 2 of 3 Brighthouse fundsFor—

Download all 244 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.3% of this fund’s 2,657 such votes could be given a sector; the other 152 (5.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care60210.2%
Consumer Discretionary53920.4%
Industrials44940.9%
Technology42620.5%
Finance18100.0%
Real Estate9700.0%
Energy8300.0%
Consumer Staples3900.0%
Miscellaneous3700.0%
Basic Materials3400.0%
Telecommunications1400.0%
Utilities400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,8180
Say-on-Pay3160
Audit-related3130
Compensation960
Corporate Governance565
Capital Structure350
Extraordinary Transactions150
Shareholder Rights and Defenses111
Other Social Issues21
Diversity, Equity, and Inclusion11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Bloom Energy CorporationMay 21, 2026$18M80
Guardant Health, Inc.June 17, 2026$16M50
BrightSpring Health Services, Inc.May 21, 2026$15M50
Rambus Inc.April 23, 2026$12M60
Applied Industrial Technologies, Inc.October 21, 2025$11M50
Watts Water Technologies, Inc.May 19, 2026$11M110
Carpenter Technology CorporationOctober 7, 2025$11M50
The Ensign Group, Inc.May 13, 2026$10M60

Notable votes against management

MeetingCompanyProposalFundMgmt
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
August 4, 2025Eagle Materials Inc.Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposalForAgainst
July 23, 2025Booz Allen Hamilton Holding CorporationVote on a stockholder proposal regarding a report on political spending. Shareholder proposalAgainstFor
June 15, 2026HubSpot, Inc.A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposalForAgainst
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor
June 3, 2026Power Integrations, Inc.To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposalAgainstFor

Search this fund’s votes by company

2,665 ballot items at 318 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Small Cap Growth Portfolio voted at 318 shareholder meetings of 313 companies, on 2,665 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 10 shareholder proposals. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (89.8% against 76.3%). It voted differently from most Brighthouse funds on 244 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.